ARTICLE | Clinical News
Rockwell gains on Phase III anemia data for SFP
July 11, 2013 11:52 PM UTC
Rockwell Medical Technologies Inc. (NASDAQ:RMTI) said 11 ug/dL Soluble Ferric Pyrophosphate (SFP) delivered via hemodialysate concentrate met the primary endpoint in the Phase III CRUISE-1 trial to tr...